Head to Head Comparison: Cellebrite DI (NASDAQ:CLBT) vs. AvePoint (NASDAQ:AVPT)

Cellebrite DI (NASDAQ:CLBTGet Free Report) and AvePoint (NASDAQ:AVPTGet Free Report) are both mid-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Cellebrite DI and AvePoint, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cellebrite DI 1 0 4 0 2.60
AvePoint 0 5 9 2 2.81

Cellebrite DI currently has a consensus target price of $24.00, suggesting a potential upside of 30.79%. AvePoint has a consensus target price of $18.94, suggesting a potential upside of 38.52%. Given AvePoint’s stronger consensus rating and higher possible upside, analysts plainly believe AvePoint is more favorable than Cellebrite DI.

Profitability

This table compares Cellebrite DI and AvePoint’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Cellebrite DI 16.74% 20.81% 10.71%
AvePoint 0.55% 0.66% 0.40%

Insider and Institutional Ownership

45.9% of Cellebrite DI shares are owned by institutional investors. Comparatively, 44.5% of AvePoint shares are owned by institutional investors. 5.7% of Cellebrite DI shares are owned by company insiders. Comparatively, 26.2% of AvePoint shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Cellebrite DI and AvePoint”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Cellebrite DI $401.20 million 10.95 -$283.01 million $0.31 59.19
AvePoint $330.48 million 8.93 -$29.09 million N/A N/A

AvePoint has lower revenue, but higher earnings than Cellebrite DI.

Risk and Volatility

Cellebrite DI has a beta of 1.28, indicating that its stock price is 28% more volatile than the S&P 500. Comparatively, AvePoint has a beta of 1.09, indicating that its stock price is 9% more volatile than the S&P 500.

Summary

Cellebrite DI beats AvePoint on 7 of the 13 factors compared between the two stocks.

About Cellebrite DI

(Get Free Report)

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company was incorporated in 1999 and is headquartered in Petah Tikva, Israel.

About AvePoint

(Get Free Report)

AvePoint, Inc. provides cloud-native data management software platform in North America, Europe, Middle East, Africa, and Asia Pacific. It also offers software-as-a-service solutions and productivity applications. The company offers modularity and cloud services architecture to address critical challenges and the management of data to organizations that leverage third-party cloud vendors, including Microsoft, Salesforce, Google, AWS, Box, DropBox, and others; license and support; and maintenance services. AvePoint, Inc. was incorporated in 2001 and is headquartered in Jersey City, New Jersey.

Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.